Rickets – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Rickets – Drugs In Development, 2024 report and make more profitable business decisions.
Rickets is a childhood disease where the bones are too soft and weak, causing them to warp, bend, and break easily. Widening of the knees, bone pain, pigeon chest, growth delay, and rachitic rosary are the symptoms of rickets. It is caused due to nutritional deficiency (vitamin D, calcium) or genetic condition that affect vitamin D absorption. X-rays, blood and urine tests, bone biopsies and genetic testing are used for diagnosis. High doses of vitamin D in diet or as a supplement, exposure to sunlight, and calcium are the treatment options.
The Rickets drugs in development market research report provide comprehensive information on the therapeutics under development for Rickets, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rickets and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Rickets | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 8 molecules, with 6 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Rickets therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Rickets pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Rickets treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
CANbridge Life Sciences LtdChangchun GeneScience Pharmaceutical Co Ltd
EPOK Therapeutics Inc
Genethon SA
Inozyme Pharma Inc
Kyowa Kirin Co Ltd
Panorama Research Institute
Ultragenyx Pharmaceutical Inc
University of Tennessee
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Rickets reports